|
Volumn 45, Issue 1-3, 2001, Pages 61-64
|
Monotherapy trials: Prerequisite data
|
Author keywords
Antiepileptic drugs; Clinical trials; Epilepsy; Monotherapy
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
GABAPENTIN;
LAMOTRIGINE;
OXCARBAZEPINE;
PHENYTOIN;
REMACEMIDE;
SODIUM CHANNEL;
TIAGABINE;
VALPROIC ACID;
VIGABATRIN;
ANTICONVULSANT THERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG WITHDRAWAL;
ELECTRIC POTENTIAL;
EPILEPSY;
HUMAN;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
PRIORITY JOURNAL;
REMISSION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ANTICONVULSANTS;
DRUG RESISTANCE;
EPILEPSY;
HUMANS;
RESEARCH DESIGN;
|
EID: 0034917877
PISSN: 09201211
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-1211(01)00218-2 Document Type: Conference Paper |
Times cited : (8)
|
References (15)
|